Medscape18d
Pharmacologic Treatments for Pulmonary Hypertension
Research into prostacyclin analogs for the treatment of WHO Group 2 PH has been limited ... Phosphodiesterase type 5; PH: Pulmonary hypertension.
Odessa American1d
Why early diagnosis of PAH is so important
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Medscape5d
Pharmacologic Treatments for Pulmonary Hypertension
[105] This trial enrolled 405 PAH patients (a majority were WHO functional class II and III) and randomized them to placebo or tadalafil 2.5, 10, 20, or 40 mg daily for 16 weeks. Compared with ...
thorax.bmj29d
P16 Identifying partial anomalous pulmonary venous drainage (PAPVD) in patients presenting with suspected pulmonary hypertension (PH)
Of the 50 patients with isolated PAPVD, 47 underwent right heart catheterisation (RHC), mean values: mean pulmonary arterial pressure (mPAP) 36.5 (±15) mmHg, pulmonary arterial wedge pressure (PAWP) ...
Managed Healthcare Executive10d
Analysis Finds Winrevair Effective Across Cardiac Index Groups
A pooled analysis of two prior trials suggests patients with a variety of cardiac index scores saw improvement when Winrevair ...
Indiatimes8d
Woman dies within 2 days of heart, lungs transplant
The woman was suffering from Eisenmenger syndrome, a condition that occurs when a congenital heart defect causes abnormal blood circulation, resulting in pulmonary hypertension and lung damage. "As ...
FierceBiotech15d
Keros' stock tanks after halting 2 arms of hypertension trial over fluid buildups around heart
Keros Therapeutics has halted dosing in two of the three treatment arms of a phase 2 trial of its pulmonary arterial ...
Business Insider8d
Levi & Korsinsky Announces an Investigation on Behalf of Keros Therapeutics, Inc. (KROS) Shareholders Who May Have Been Affected by Fraud
a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy in patients with pulmonary arterial hypertension ("PAH"), based on a safety review due to the unanticipated ...
The American Journal of Managed Care16d
New Study Evaluates Quality-of-Life Instruments for Patients With PAH
CAMPHOR and PAH-SYMPACT are the most reliable QOL tools for PAH, with Grade A ratings for internal reliability. LPHQ and ...
Business Insider9d
ATTENTION KROS SHAREHOLDERS: Investors who lost money on Keros Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy in patients with pulmonary arterial hypertension ("PAH"), based on a safety review due to the unanticipated ...
Keros Shares Dive on Halt to Trial of Pulmonary Hypertension Treatment
The company said the unanticipated events of pericardial effusion--when fluid builds up in the space around the heart--came in the Phase 2 clinical trial of 3 milligrams per kilogram and 4.6 mg/kg ...
thecardiologyadvisor.com11d
Lipodermatosclerosis Is Rare in SSc But Linked to Pulmonary Hypertension
Lipodermatosclerosis (LDS) was observed in 4.4% of patients with systemic sclerosis (SSc) and was associated with pulmonary hypertension (PH), according ... or died whereas 115 patients without LDS ...